Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Von Willebrand factor A domain containing 8 pseudogene 1 (VWA8P1)** is a predicted **pseudogene** in the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but generally non-functional; they usually lack the ability to encode a functional protein due to accumulated disablements[5][2]. VWA8P1 is annotated as a pseudogene related to the VWA8 gene, which encodes a mitochondrial AAA+ ATPase with a Von Willebrand factor A (vWA) domain, but there is no evidence that VWA8P1 acts as a therapeutic target, is biologically functional, expressed as RNA, or encodes a protein in humans[5][3]. There is no evidence implicating VWA8P1 in human disease biology, drug interaction, or use as a clinical biomarker. The entry "VWA8P1" is not a functional protein-coding gene or receptor, and there is no indication it should be considered a therapeutic target[5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Von Willebrand factor A domain containing 8 pseudogene 1 (VWA8P1).